Idexx Laboratories (IDXX) P/E (2010 - 2026)
Idexx Laboratories (IDXX) P/E from Jun 30, 2010 to Jul 23, 2026. The TTM Idexx Laboratories (IDXX) P/E is 39.29. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Idexx Laboratories (IDXX)
| Year | P/E | Change |
|---|---|---|
| 2026 | 39.29 | -23.23% |
| 2025 | 51.17 | +33.61% |
| 2024 | 38.30 | -31.61% |
| 2023 | 56.00 | +9.71% |
| 2022 | 51.05 | -32.06% |
| 2021 | 75.14 | +2.64% |
| 2020 | 73.21 | +39.60% |
| 2019 | 52.44 | +22.77% |
| 2018 | 42.72 | -12.95% |
| 2017 | 49.07 | -0.71% |
| 2016 | 49.42 | +26.56% |
| 2015 | 39.05 | -4.71% |
| 2014 | 40.98 | +34.04% |
| 2013 | 30.57 | +3.09% |
| 2012 | 29.66 | +6.67% |
| 2011 | 27.80 | -49.95% |
| 2010 | 55.55 | N/A |
Comparison Idexx Laboratories (IDXX) P/E with competitors
Idexx Laboratories (IDXX) P/E is 39.29.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| MBAI | CheckCap Ltd | 1.71 | -95.64% |
| ADVB | Advanced Biomed Inc | 2.46 | -93.74% |
| FONR | Fonar Corp | 15.48 | -60.60% |
| QGEN | Qiagen NV | 19.70 | -49.85% |
| DGX | Quest Diagnostics Inc | 23.39 | -40.46% |
| IQV | IQVIA Holdings Inc | 24.27 | -38.22% |
| LH | Laboratory Corp Of America Holdings | 24.70 | -37.13% |
| A | Agilent Technologies Inc | 26.70 | -32.04% |
| TMO | Thermo Fisher Scientific Inc | 31.01 | -21.07% |
| DHR | Danaher Corp | 31.59 | -19.59% |
| MTD | Mettler-Toledo International Inc | 31.69 | -19.33% |
| MEDP | Medpace Holdings Inc | 32.48 | -17.33% |
| ILMN | Illumina Inc | 45.00 | +14.53% |
| RVTY | Revvity Inc | 52.30 | +33.11% |
| VCYT | Veracyte Inc | 52.36 | +33.26% |
| SHC | Sotera Health Company | 70.57 | +79.63% |
| WAT | Waters Corp | 101.66 | +158.75% |